AMAG Pharma (AMAG) Reports Q1 Loss of $0.72/sh

AMAG Pharma (NASDAQ: AMAG) reported Q1 EPS of ($0.72), versus ($3.54) reported last year. Revenue for the quarter came in at $68.7 million versus the consensus estimate of $64.82 million.

For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Deere shares climb as fiscal Q3 earnings and revenue top estimates
• Walmart shares fall despite earnings beat